Investigation of the effect of heating on the chemistry and antifactor Xa activity of enoxaparin - PubMed (original) (raw)
. 2009 May;98(5):1700-11.
doi: 10.1002/jps.21556.
Affiliations
- PMID: 18979533
- DOI: 10.1002/jps.21556
Investigation of the effect of heating on the chemistry and antifactor Xa activity of enoxaparin
Rahul P Patel et al. J Pharm Sci. 2009 May.
Abstract
The objective of this study was to investigate the effects of heating on the chemistry, physical properties and antifactor Xa activity of enoxaparin. Samples of enoxaparin heated at 70 degrees C lost 27% of their initial AFXa activity after 8 h, then activity increased to 94% of the initial activity over the next 4 h. Activity then decreased to 84% of control after 48 h and further to 80% of control over 22 days. The initial activity loss correlated with desulfation as demonstrated by sulfate and amine analysis. Fragmentation of oligosaccharides occurred, as demonstrated by reducing capacity and capillary electrophoresis analysis. Individual enoxaparin fractions obtained by high performance size exclusion chromatography were analysed. Early eluting fractions, containing aggregated oligosaccharides, increased in concentration following heating. Up to 65% of sulfate was lost from some fractions, containing hexa- and octa-saccharides, after 8 h, corresponding with decreased activity. Low mass oligosaccharide fractions increased in concentration and had increased activity between 8 and 12 h. Reversed-phase ion-interaction HPLC analysis supported these findings. Deca-, dodeca- and tetradeca-saccharides were resistant to thermal degradation. Desulfation, fragmentation and aggregation occur during the heating of enoxaparin and result in the initial rapid loss, recovery and subsequent gradual loss of activity.
Similar articles
- Investigation of freezing- and thawing-induced biological, chemical, and physical changes to enoxaparin solution.
Patel RP, Narkowicz C, Jacobson GA. Patel RP, et al. J Pharm Sci. 2009 Mar;98(3):1118-28. doi: 10.1002/jps.21483. J Pharm Sci. 2009. PMID: 18661541 - Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Dager WE, Gosselin RC, King JH, Christensen CL, Owings JT, Larkin EC. Dager WE, et al. Ann Pharmacother. 2004 Apr;38(4):569-73. doi: 10.1345/aph.1D107. Epub 2004 Feb 24. Ann Pharmacother. 2004. PMID: 14982984 - Ion exchange chromatographic separation and isolation of oligosaccharides of intact low-molecular-weight heparin for the determination of their anticoagulant and anti-inflammatory properties.
Shastri MD, Johns C, Hutchinson JP, Khandagale M, Patel RP. Shastri MD, et al. Anal Bioanal Chem. 2013 Jul;405(18):6043-52. doi: 10.1007/s00216-013-6996-9. Epub 2013 May 28. Anal Bioanal Chem. 2013. PMID: 23712644 - In vitro stability of enoxaparin solutions (20 mg/mL) diluted in 4% glucose.
Patel RP, Narkowicz C, Jacobson GA. Patel RP, et al. Clin Ther. 2008 Oct;30(10):1880-5. doi: 10.1016/j.clinthera.2008.10.014. Clin Ther. 2008. PMID: 19014843 - Enoxaparin in acute coronary syndromes.
Lee S, Gibson CM. Lee S, et al. Expert Rev Cardiovasc Ther. 2007 May;5(3):387-99. doi: 10.1586/14779072.5.3.387. Expert Rev Cardiovasc Ther. 2007. PMID: 17489664 Review.
Cited by
- Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics.
Shastri MD, Stewart N, Eapen M, Peterson GM, Zaidi ST, Gueven N, Sohal SS, Patel RP. Shastri MD, et al. PLoS One. 2015 Mar 4;10(3):e0118798. doi: 10.1371/journal.pone.0118798. eCollection 2015. PLoS One. 2015. PMID: 25738575 Free PMC article. - Not Just Anticoagulation-New and Old Applications of Heparin.
Zang L, Zhu H, Wang K, Liu Y, Yu F, Zhao W. Zang L, et al. Molecules. 2022 Oct 17;27(20):6968. doi: 10.3390/molecules27206968. Molecules. 2022. PMID: 36296562 Free PMC article. Review. - Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.
Patel RP, Shastri MD, Ming LC, Zaidi STR, Peterson GM. Patel RP, et al. Front Pharmacol. 2018 Jun 5;9:586. doi: 10.3389/fphar.2018.00586. eCollection 2018. Front Pharmacol. 2018. PMID: 29922163 Free PMC article. Review. - Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals.
Shastri MD, Stewart N, Horne J, Zaidi ST, Sohal SS, Peterson GM, Korner H, Gueven N, Patel RP. Shastri MD, et al. PLoS One. 2015 Jun 5;10(6):e0128803. doi: 10.1371/journal.pone.0128803. eCollection 2015. PLoS One. 2015. PMID: 26046354 Free PMC article. - Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.
Akhtar F, Wan X, Wu G, Kesse S, Wang S, He S. Akhtar F, et al. Molecules. 2018 Jul 18;23(7):1757. doi: 10.3390/molecules23071757. Molecules. 2018. PMID: 30021958 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical